Nasr, D.; Moein, M.; Niforatos, S.; Nasr, S.; Ombada, M.; Khokhar, F.; Shahnawaz, M.; Poudyal, B.; Bou Zerdan, M.; Dutta, D.;
et al. Piperacillin/Tazobactam and Meropenem Use Increases the Risks for Acute Graft Rejection Following First Kidney Transplantation. J. Clin. Med. 2022, 11, 2726.
https://doi.org/10.3390/jcm11102726
AMA Style
Nasr D, Moein M, Niforatos S, Nasr S, Ombada M, Khokhar F, Shahnawaz M, Poudyal B, Bou Zerdan M, Dutta D,
et al. Piperacillin/Tazobactam and Meropenem Use Increases the Risks for Acute Graft Rejection Following First Kidney Transplantation. Journal of Clinical Medicine. 2022; 11(10):2726.
https://doi.org/10.3390/jcm11102726
Chicago/Turabian Style
Nasr, Dayana, Mahmoudreza Moein, Stephanie Niforatos, Sandy Nasr, Mulham Ombada, Farzam Khokhar, Myera Shahnawaz, Bhavya Poudyal, Maroun Bou Zerdan, Dibyendu Dutta,
and et al. 2022. "Piperacillin/Tazobactam and Meropenem Use Increases the Risks for Acute Graft Rejection Following First Kidney Transplantation" Journal of Clinical Medicine 11, no. 10: 2726.
https://doi.org/10.3390/jcm11102726
APA Style
Nasr, D., Moein, M., Niforatos, S., Nasr, S., Ombada, M., Khokhar, F., Shahnawaz, M., Poudyal, B., Bou Zerdan, M., Dutta, D., Saidi, R. F., & Lim, S. H.
(2022). Piperacillin/Tazobactam and Meropenem Use Increases the Risks for Acute Graft Rejection Following First Kidney Transplantation. Journal of Clinical Medicine, 11(10), 2726.
https://doi.org/10.3390/jcm11102726